Insider

George L Sing

Director · Regeneron Pharmaceuticals, Inc. (REGN)

sold: $20,376,358 · planned sales: $1,917,952

DateTradeSharesAvg. priceValueFiling
November 17, 2026Planned sale1,000—$957,687SEC
November 16, 2026Planned sale1,000—$960,264SEC
November 2, 2026Sale notice filed21,129$964.38$20,376,358SEC

Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.